Nutritional Transitions to More Plant Proteins and Less Animal Proteins: Understanding the Induced Metabolic Reorientations and Searching for Their Biomarkers (ProVegOmics) (ProVegOmics)

Nutritional Transitions to More Plant Proteins and Less Animal Proteins: Understanding the Induced Metabolic Reorientations and Searching for Their Biomarkers (ProVegOmics)

Nutritional Transitions to More Plant Proteins and Less Animal Proteins: Understanding the Induced Metabolic Reorientations and Searching for Their Biomarkers

UMR 1019, Unité de Nutrition Humaine, INRA, Centre Auvergne-Rhône Alpes, UMR 0914, Physiologie de la Nutrition et du Comportement Alimentaire, AgroParistech (adresse si besoin: 16 rue Claude Bernard, 75231 Paris Cedex 05).

The dietary shift from animal to plant protein sources is one of the key aspects of the nutritional transition towards more sustainable food system and diets. However the metabolic implication of this shift in protein sources are still poorly understood. This project aims to characterize and understand the metabolic orientations specifically induced by animal and vegetable dietary proteins, in order to better analyze the metabolic reorientations that would result from the expected increase in the share of plant proteins in different dietary contexts, especially those of the Western type, often associated with the development of metabolic deregulations (obesity and cardiometabolic risk).

The main objectives of this project are: Characterize the metabolic adaptations induced by animal or plant protein diets and their repercussions in terms of physiology and health. Characterize the medium-term metabolomic signatures induced by this shift in dietary protein sources Validate, in a human population, biomarkers of dietary animal or plant proteins, previously identified in pre-clinical studies. This clinical trial is open, monocentric, controlled, randomized, with a cross experimental design. 20 men or postmenopausal women will follow for 4 weeks a controlled diet with a protein fraction constituted mainly from animal or vegetal sources. After a 2-week washout period(+21D/-7D), they will follow another 4 week of controlled diet with predominantly animal or plant protein depending on 1st intervention period diet. At the end of each intervention period, a post-prandial exploration will be conducted with the administration of a high-fat, high-sugar meal and subsequent blood and urine sampling. The order in which participants will received the two diets will be randomized.

Metabolic Syndrome, Hypertriglyceridemia, Fasting Blood Sugar Above Normal, Lower Than Standard HDL-cholesterol Level, Slightly Elevated Blood Pressure

Metabolomics, Plant Proteins, Dietary, Meat Proteins, Dietary Proteins, Metabolic Syndrome, Hypertriglyceridemia, Waist Circumference

20 men or postmenopausal women between 25 and 55 years old with a high waist circumference and at the choice, one of the following criteria high triglyceridemia, blood sugar above standards,a lower than standard HDL-cholesterol level,slightly elevated blood pressure receiving diets with predominantly animal protein sources

20 men or postmenopausal women between 25 and 55 years old with a high waist circumference and at the choice, one of the following criteria high triglyceridemia, blood sugar above standards,a lower than standard HDL-cholesterol level,slightly elevated blood pressure receiving diets with predominantly plant protein sources

20 men or postmenopausal women will follow for 4 weeks a controlled diet with a protein fraction constituted mainly from animal sources. At the end of the intervention period, a post-prandial exploration will be conducted with the administration of a high-fat, high-sugar meal and subsequent blood and urine sampling.

20 men or postmenopausal women will follow for 4 weeks a controlled diet with a protein fraction constituted mainly from vegetal sources. At the end of the intervention period, a post-prandial exploration will be conducted with the administration of a high-fat, high-sugar meal and subsequent blood and urine sampling.

will be determined by measuring minimal and maximal diameter of brachial artery in mm and the percentage of dilatation using the Flow-Mediated Dilatation GE echographer

will be determined by measuring minimal and maximal diameter of brachial artery in mm and the percentage of dilatation using the Flow-Mediated Dilatation GE echographer

will be determined by measuring minimal and maximal diameter of brachial artery in mm and the percentage of dilatation using the Flow-Mediated Dilatation GE echographer

will be determined by measuring minimal and maximal diameter of brachial artery in mm and the percentage of dilatation using the Flow-Mediated Dilatation GE echographer

will be determined by the identification of bacterial biodiversity by a genetic sequencing analysis of bacterial DNA

will be determined by the identification of bacterial biodiversity by a genetic sequencing analysis of bacterial DNA

will be determined by the identification of bacterial biodiversity by a genetic sequencing analysis of bacterial DNA

will be determined by the identification of bacterial biodiversity by a genetic sequencing analysis of bacterial DNA

will be determined by the identification of bacterial biodiversity by a genetic sequencing analysis of bacterial DNA

will be determined by the identification of bacterial biodiversity by a genetic sequencing analysis of bacterial DNA

will be determined by the identification of bacterial biodiversity by a genetic sequencing analysis of bacterial DNA

will be determined by the identification of bacterial biodiversity by a genetic sequencing analysis of bacterial DNA

Inclusion Criteria: BMI between 25 and 35 kh/m² (terminals included) Waist circumference ≥ 94 cm for men and ≥80 cm for women at the choice, one of the following criteria: Triglyceridemia > 1.49g/L, fasting blood glucose≥ 5.6 mmol/L , a HDL cholesterol <1.03mmol/L for men or <1.29 mmol/L for women , systolic blood pressure≥ 130 mmHg or diastolic≥ 85 mmHg . Exclusion Criteria: Systolic blood pressure > 150mmHg or diastolic blood pressure > 90mmHg pathology and medical treatment diabetes Smoking > 4 cigarettes /day Alcohol consumption > 2 glasses/day Antibiotics taken during the last 3 months before the clinical trial Specific diets